# Mira Pharmaceuticals, Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [Mira Pharmaceuticals, Inc.](/companies/mira.md) (CIK 1904286)
- Form: 10-K/A
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 21:28 ET
- Period: 2024-12-31
- Accession: 0001641172-25-005313
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1904286/000164117225005313/form10-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1904286/000164117225005313/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1904286/000164117225005313/form10-ka.htm

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-005313. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.